HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1,821: | Line 1,821: | ||
|- | |- | ||
|Burkitt lymphoma||Disease|| || || || || ||GC|| || | |Burkitt lymphoma||Disease|| || || || || ||GC|| || | ||
| | |Burkitt Lymphoma | ||
|Becky Leung, MBBS (Hons), BSc, Pathology Queensland | |Becky Leung, MBBS (Hons), BSc, Pathology Queensland | ||
| | |Complete | ||
| | |28/06/2021 | ||
| | | | ||
|- | |- | ||
|Primary effusion lymphoma||Disease|| || || || || ||GC|| || | |Primary effusion lymphoma||Disease|| || || || || ||GC|| || | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|KSHV/HHV8-positive diffuse large B-cell lymphoma||Disease|| || || || || ||GC|| || | |KSHV/HHV8-positive diffuse large B-cell lymphoma||Disease|| || || || || ||GC|| || | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|KSHV/HHV8-positive germinotropic lymphoproliferative disorder||Disease|| || || || || ||GC|| || | |KSHV/HHV8-positive germinotropic lymphoproliferative disorder||Disease|| || || || || ||GC|| || | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Hyperplasias arising in immune deficiency/dysregulation||Disease|| || || || || ||GC|| || | |Hyperplasias arising in immune deficiency/dysregulation||Disease||FIX ISSUE! (on 5th edition page instructions say "encompassing non-destructive post-transplant lymphoproliferative disorders, among others")|| || || || ||GC|| || | ||
| | | | ||
| | | | ||
| Line 1,855: | Line 1,855: | ||
| | | | ||
|- | |- | ||
|Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation||Disease|| | |Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation||Disease||FIX ISSUE! (on 5th edition page instructions say ""This page was converted to the new template on 2023-12-07. The original page can be found at [[HAEM4:Polymorphic Post-Transplant Lymphoproliferative Disorders]]. | ||
| | Note: encompassing polymorphic PTLD, other iatrogenic immunodef-assoc lympho disorders, among others) | ||
| || || || ||GC|| || | |||
|Polymorphic Post-Transplant Lymphoproliferative Disorders | |||
|Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI) | |Anna Shestakova, MD, PhD, Fellow, University of Utah/ARUP Laboratories Fabiola Quintero-Rivera, MD, Professor, University of California Irvine (UCI) | ||
| | |Completed | ||
| | |26/4/2022 | ||
| | | | ||
|- | |- | ||